Google
NYXH — NYXOAH (Healthcare >> Medical Instruments & Supplies)
NYXH FAQ
What is NYXH's ROE?
NYXOAH reports a Return on Equity (ROE) of -239.18%.
What is NYXH's dividend yield?
NYXOAH offers a dividend yield of 0.00%.
What is NYXH's Deepscope Quality Score?
Deepscope rates NYXH's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy NYXH?
Deepscope's AI Timing Score for NYXH is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does NYXH belong to?
NYXOAH is classified under the Healthcare >> Medical Instruments & Supplies sector on the NASDAQ exchange.
|
USD 2.88
Price
0.01
(0.35%)
Day Change
|
|
|---|
NYXH, the overall quality is not good ( Quality = 23) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
Negative growth of ROE in the last year.
ROE is decreasing significantly
Growth of ROA was below our criteria in the last year.
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Quality Factors |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 88 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 2.88 |
| PBV / Sector |
3.69 / 4.37
|
| Earning Per Share | -1.87 |
| PE / Sector |
N/A / 36.10
|
| PEG or PE/Growth / Sector |
N/A / -1.23
|
| Average 1M Daily Value |
0.13 M
GREAT
|
| Average 1W Daily Value |
0.06 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
45% |
| Ability to Make Profit |
|
52% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-05 09:11:55 |
| Symbol | NYXH |
| Name | NYXOAH |
| Sector | Healthcare >> Medical Instruments & Supplies |
| Market | NASDAQ |
| Listed Shares | 44.69 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 132.74 / 15,809.81 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: Rue Edouard Belin 12, Mont-Saint-Guibert, Belgium, 1435
Phone: 32 1 045 90 75
Website: https://www.nyxoah.com
Employees: 153
Description: Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
ME vs SECTOR Healthcare >> Medical Instruments & Supplies
Click a bubble to view stock details · Bubble size represents market capitalization share
